Thursday, 22 Jun 2017

You are here

High Fiber Intake May Decrease Osteoarthritis Knee Pain

 

Dai, Felson and colleagues report in Annals of Rheumatic Disease that high dietary fiber lowers the risk of symptomatic osteoathritis (SxOA), but the radiographic benefits remain unclear. (Citation source http://buff.ly/2rHv9yd)

They analyzed longitudinal data from 2 studies 1) the Osteoarthritis Initiative (OAI; n =4796) and the Framingham Offspring Osteoarthritis Study (FOOS; n=1268) and assessed their dietary fiber intake in addition to whether the patient had SxOA or radiographic OA (ROA). 

In both OAI and FOOS cohorts, total dietary fiber was inversely associated with risk of SxOA (p trend <0.03) with significantly lower risk at the highest versus lowest quartile (OR (95% CI): 0.70 (0.52, 0.94) for OAI and 0.39 (0.17, 0.88) for Framingham).

Fiber intake was also \significantly inversely associated with knee pain worsening, but no apparent association was seen with with ROA and fiber intake.ROA was unclear.

The NY Times reports that that average fiber intake among U.S. adults is about 15 grams; which is below the 22.4 grams recommended for women and 28 grams per day recommended for for men.

It is postulated that high fiber intake may be beneficial by being "anti-inflammatory" or by promoting weight reduction or other lifestyle modifications that benefit the joints. 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Bone Turnover Markers in Practice: A Guide for the Rheumatologist

Bone turnover markers (BTMs) have been eyed for decades as potential monitoring tools in osteoporosis.

However there have been difficulties with poor between-lab reproductivity, insufficiently controlled heterogeneity, and pre-analytical variability of the assays; making BTMs vastly unpopular amongst practicing rheumatologists.

2017 ACR Guideline on Glucocorticoid-Induced Osteoporosis

The American College of Rheumatology has updated its 2010 guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. The guideline provides recommendations on assessing fracture risk and treatment for adults and special patient populations, including women of childbearing potential, adults treated with very high-dose glucocorticoids, adults with organ transplants, and children ages 4-17.

Higher Fracture Risks with Prolonged Bisphosphonate Use in Older Women

The Journal of the American Geriatric Society has reported that older women receiving bisphosphonate therapy for greater than 10-13 years were more likely to suffer from fractures.

Chondroitin Effective in Knee OA. Or is it?

Reginster and colleagues have reported on the results of the CONCEPT trial showing that osteoarthritis (OA) patients treated 800 mg/day of  pharmaceutical-grade chondroitin sulfate (CS) have less VAS pain scores and improved function over 6 months therapy. These results were superior to placebo and equivalent to celecoxib in reducing in symptomatic OA knee pain.

Anti-Sclerostin Drug Hampered by Heart Problems

Reuters reports that FDA approval of romosozumab (brand name Evenity) may be held up because of higher rates of cardiac events seen in a late-stage clinical trial.